865758-96-9Relevant articles and documents
Preparation method of alogliptin benzoate intermediate and preparation method of alogliptin benzoate
-
Paragraph 0074-0079; 0092-0095, (2021/08/28)
The invention provides a reparation method of an alogliptin benzoate intermediate and a preparation method of alogliptin benzoate. The yield of the alogliptin benzoate intermediate prepared by the method is not lower than 88%, and the purity is not lower than 99.5%; and according to the alogliptin benzoate raw material medicine prepared by the method, D90 does not exceed 220 microns, and preferably does not exceed 200 microns. All indexes of the prepared pharmaceutical composition meet medicinal requirements, the quality is stable in the storage process, and the clinical curative effect and medication safety can be guaranteed.
Preparation method of alogliptin benzoate
-
Paragraph 0028-0029; 0033-0034, (2021/01/29)
The invention discloses a preparation method of alogliptin benzoate. Main starting materials of the preparation method are 6-chloro-3-methyluracil, o-cyanobenzyl bromide, (R)-3-Boc-aminopiperidine andbenzoic acid. According to the method, all indexes meet the specification, meanwhile, dangerous reagents such as sodium hydride and highly toxic methyl iodide are prevented from being used in the reaction process, the requirement for the operation process is not strict, and water-free and oxygen-free conditions are not needed; a high-boiling-point mixed solvent is not used in the reaction, and the solvent is easy to recycle; the selected starting materials are available in the market and easy to obtain, and large-scale production is facilitated; in addition, starting materials or intermediates in the synthetic route are good in stability and convenient to store and control, and genotoxic impurities are avoided in the reaction process; and the synthesis process is environment-friendly.
Refining method of alogliptin benzoate
-
Paragraph 0116-0118, (2021/06/06)
The invention discloses a refining method of alogliptin benzoate, which is characterized in that an alogliptin benzoate crude product (the purity is 99.73%) is used as a starting raw material, the alogliptin benzoate crude product is dissolved by adding an organic solvent, and is cooled to crystallize to obtain a high-purity target product alogliptin benzoate solid, and the purity of the alogliptin benzoate solid can reach 99.99% through HPLC detection. Compared with the prior art, the toxicity of the used solvent is low, the mother liquor solvent can be recycled, and the environmental pollution is small; and the operation is simple and feasible, and industrial large-scale production is facilitated.